Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration

PBS NewsHour
by Michelle Chapman, Associated Press
March 9, 2026
2 views
2 min read

Quick Insights

The Bottom Line

Novo Nordisk dropped its lawsuit against Hims & Hers and will now partner to offer weight loss medications.

How This Affects You

You may have more access to Novo Nordisk weight loss medications through Hims & Hers, potentially at self-pay prices.

AI Summary

Novo Nordisk has withdrawn its lawsuit against Hims & Hers, initiating a new collaboration between the two pharmaceutical companies. Hims & Hers will now offer Novo Nordisk's weight loss medications at "self-pay prices" through its platform. This partnership follows Novo Nordisk's previous legal action regarding Hims & Hers' sale of off-brand versions of its drugs. The agreement shifts the dynamic from litigation to a direct commercial arrangement for the distribution of these medications. This development could impact market access and pricing strategies for weight loss treatments.

What's Being Done

Novo Nordisk dropped its lawsuit against Hims & Hers and will now collaborate to offer weight loss medications.

Should this be getting more attention?

You Might Have Missed

Related stories from different sources and perspectives

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration - AP News
Corporate

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration - AP News

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQMnQ1d1I3MmlaaC1ZcGJic1lwc3pCMTV4N2NicDQ3dnZTV1JlR0FrUTFZRHNEVWFWWnNHNnJIMTZveXF2bXpWY09QT1BwZWd3STlhS2hpOHRNVEQ3cThmTWZZWFBVLURWWHl1TC1Vb3U0T2JPZk1iYVNmYVNBVXJaZm1tNno1czZRRFJ6Wjh0NHBSdU9EVTZWd1YtUGtRX3BFZUcw?oc=5" target="_blank">Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration</a>&nbsp;&nbsp;<font color="#6f6f6f">AP News</font>

AP NewsMar 9
Novo Nordisk deal lets Hims sell Wegovy and Ozempic, drops lawsuit - USA Today
Corporate

Novo Nordisk deal lets Hims sell Wegovy and Ozempic, drops lawsuit - USA Today

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNUlF3ODNIWWFSd1VlODRWdi04NUlldEl6SXJmd2tNdVpZWVRzYW95YnBZNXNlbVlhQl9HZHB0Smo0TTJpWDBTTTQtTzc0LXJoTnUxY3JmakxpSmI2WnVRdVFtN0lzVWVxa1JRWXlMSThiY3Z5R3ZYQ3FJQWd4cU85bjA4aTFJbmxQcmlOcGpaa2FJWlM4NmRad1hSOEVwdw?oc=5" target="_blank">Novo Nordisk deal lets Hims sell Wegovy and Ozempic, drops lawsuit</a>&nbsp;&nbsp;<font color="#6f6f6f">USA Today</font>

USA TodayMar 9
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Health

FDA warns Novo Nordisk over unreported potential Ozempic side effects

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.

CBS NewsMar 10
FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
Health

FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and Wegovy. The FDA wrote in a March 5 letter that it observed “serious violations” of reporting requirements during…

The HillMar 10
Trump is using immigration policy to suppress speech, lawsuit claims
Civil Rights

Trump is using immigration policy to suppress speech, lawsuit claims

A new lawsuit accuses the administration of violating the First Amendment by threatening the visas of researchers for work on disinformation and content moderation of social media.<br><br>

NPRMar 9
New Lawsuit Challenges Rubio’s Threats Against Foreign Tech Regulators
Politics

New Lawsuit Challenges Rubio’s Threats Against Foreign Tech Regulators

A lawsuit filed on Monday argues that a State Department’s decision to withhold visas from experts who have pushed for stronger social media regulations is illegal.

New York TimesMar 9
Read Next
US, Japan agree on their roles in potential nuclear power project, Westinghouse says - Reuters
Corporate

US, Japan agree on their roles in potential nuclear power project, Westinghouse says - Reuters

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQSWtjM1lUQW12N1hJQlBkU2d6V2o5THBxbWtWMWJFOHhzRXd0V3ljNlB6U1hFVDVVT3YyVDJaclByUTJ0dWIwbk9ZMUFIaFVSVDdHZ1dYZjVLQTBlNVFjTURZd1NrNWJjd19BcENoYUJXOVcwaUczRFNXSnVYOW4zT0ZLRi1PbXFReUhvVm12Y1BoaHpIUWQ2XzRNNTV1ZVo0LVdZcmZaRkZKaEVLX0VBSW9scUtWY0U2N3ZPQjBQMW1ubWtWcFpj?oc=5" target="_blank">US, Japan agree on their roles in potential nuclear power project, Westinghouse says</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

Continue reading

Did this story change how you see things?

Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.

Share this story

Get the daily digest

Save for later

The Verity Ledger curates verified investigative journalism from trusted sources only.

See our sources